Different stress-related gene expression in depression and suicide

Journal of Psychiatric Research

Volumn 68, Issue , 2015, Pages 176-185

  Zhao, J ^a   Qi, X R ^a   Gao, S F ^a,b   Lu, J ^a,b   van Wamelen, D J ^a,c   Kamphuis, W ^a   Bao, A M ^b   Swaab, D F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anterior cingulate cortex; Depression; Dorsolateral prefrontal cortex; Gene expression; Suicide

Indexed keywords

5 HYDROXYTRYPTAMINE RECEPTOR 1A; BENZODIAZEPINE DERIVATIVE; BRAIN DERIVED NEUROTROPHIC FACTOR; CHAPERONE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN-RELEASING HORMONE BINDING PROTEIN; CYTOCHROME; CYTOKINE; GLUCOCORTICOID RECEPTOR; LITHIUM; MINERALOCORTICOID RECEPTOR; MONOAMINE; MONOAMINE OXIDASE INHIBITOR; NITRIC OXIDE SYNTHASE; RETINOID; SEROTONIN ANTAGONIST; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRANSCRIPTION FACTOR; TROPOMYOSIN RELATED KINASE B; UNCLASSIFIED DRUG; MESSENGER RNA;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; BRAIN; BRAIN WEIGHT; CONTROLLED STUDY; DEPRESSION; DORSOLATERAL PREFRONTAL CORTEX; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUBSTANCE ABUSE; SUICIDE; VERY ELDERLY; CINGULATE GYRUS; GENETICS; HEALTH CARE FACILITY; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR DEPRESSION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREFRONTAL CORTEX; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; DEPRESSIVE DISORDER, MAJOR; GENE EXPRESSION; GYRUS CINGULI; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; PREFRONTAL CORTEX; RNA, MESSENGER; SUICIDE; TISSUE BANKS; YOUNG ADULT;

EID: 84937843404     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.06.010     Document Type: Article

References (53)

1. Arango V., Underwood M.D., Mann J.J. Postmortem findings in suicide victims. Implications for invivo imaging studies. Ann. N. Y. Acad. Sci. 1997, 836:269-287.
2. Arranz B., Eriksson A., Mellerup E., Plenge P., Marcusson J. Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol. Psychiatry 1994, 35:457-463.
3. Bao A.M., Meynen G., Swaab D.F. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res. Rev. 2008, 57:531-553.
4. Bernard R., Kerman I.A., Thompson R.C., Jones E.G., Bunney W.E., Barchas J.D., Schatzberg A.F., Myers R.M., Akil H., Watson S.J. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol. Psychiatry 2011, 16:634-646.
5. Braquehais M.D., Picouto M.D., Casas M., Sher L. Hypothalamic-pituitary-adrenal axis dysfunction as a neurobiological correlate of emotion dysregulation in adolescent suicide. World J. Pediatr. 2012, 8:197-206.
6. Cheetham S.C., Crompton M.R., Katona C.L., Horton R.W. Brain 5-HT1 binding sites in depressed suicides. Psychopharmacologyogy (Berl) 1990, 102:544-548.
7. Cotter D., Mackay D., Landau S., Kerwin R., Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 2001, 58:545-553.
8. Dillon K.A., Gross-Isseroff R., Israeli M., Biegon A. Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol. Brain Res. 1991, 554:56-64.
9. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J.Neurosci. 1993, 13:3839-3847.
10. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct. Funct. 2008, 213:93-118.
11. Dwivedi Y., Mondal A.C., Rizavi H.S., Faludi G., Palkovits M., Sarosi A., Conley R.R., Pandey G.N. Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victims. Arch. Gen. Psychiatry 2006, 63:639-648.
12. Dwivedi Y., Rizavi H.S., Conley R.R., Pandey G.N. ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol. Psychiatry 2006, 11:86-98.
13. Elliott R., Zahn R., Deakin J.F., Anderson I.M. Affective cognition and its disruption in mood disorders. Neuropsychopharmacology 2011, 36:153-182.
14. Ernst C., Deleva V., Deng X., Sequeira A., Pomarenski A., Klempan T., Ernst N., Quirion R., Gratton A., Szyf M., Turecki G. Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch. Gen. Psychiatry 2009, 66:22-32.
15. Gao S.F., Qi X.R., Zhao J., Balesar R., Bao A.M., Swaab D.F. Decreased NOS1 expression in the anterior cingulate cortex in depression. Cereb. Cortex 2013, 23:2956-2964.
16. Gross-Isseroff R., Biegon A., Voet H., Weizman A. The suicide brain: a review of postmortem receptor/transporter binding studies. Neurosci. Biobehav. Rev. 1998, 22:653-661.
17. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J.Affect Disord. 2001, 62:77-91.
18. Hu P., Liu J., Zhao J., Qi X.R., Qi C.C., Lucassen P.J., Zhou J.N. All-trans retinoic acid-induced hypothalamus-pituitary-adrenal hyperactivity involves glucocorticoid receptor dysregulation. Transl. Psychiatry 2013, 3:e336.
19. Jokinen J., Nordstrom P. HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients. J.Affect Disord. 2009, 116:117-120.
20. Jovanovic H., Perski A., Berglund H., Savic I. Chronic stress is linked to 5-HT(1A) receptor changes and functional disintegration of the limbic networks. Neuroimage 2011, 55:1178-1188.
21. Kishi T., Yoshimura R., Fukuo Y., Okochi T., Matsunaga S., Umene-Nakano W., Nakamura J., Serretti A., Correll C.U., Kane J.M., Iwata N. The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder. Eur. Arch. Psychiatry Clin. Neurosci. 2013, 263:105-118.
22. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., Sequeira A., Kushwaha N., Morris S.J., Basak A., Ou X.M., Albert P.R. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J.Neurosci. 2003, 23:8788-8799.
23. Lowther S., De Paermentier F., Cheetham S.C., Crompton M.R., Katona C.L., Horton R.W. 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. J.Affect Disord. 1997, 42:199-207.
24. Lu A., Steiner M.A., Whittle N., Vogl A.M., Walser S.M., Ableitner M., Refojo D., Ekker M., Rubenstein J.L., Stalla G.K., Singewald N., Holsboer F., Wotjak C.T., Wurst W., Deussing J.M. Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior. Mol. Psychiatry 2008, 13:1028-1042.
25. Mandelli L., Serretti A. Gene environment interaction studies in depression and suicidal behavior: an update. Neurosci. Biobehav. Rev. 2013, 37:2375-2397.
26. Mann J.J. Neurobiology of suicidal behaviour. Nat. Rev. Neurosci. 2003, 4:819-828.
27. Martins-de-Souza D., Guest P.C., Harris L.W., Vanattou-Saifoudine N., Webster M.J., Rahmoune H., Bahn S. Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients. Transl. Psychiatry 2012, 2:e87.
28. Maussion G., Yang J., Suderman M., Diallo A., Nagy C., Arnovitz M., Mechawar N., Turecki G. Functional DNA methylation in a transcript specific 3'UTR region of TrkB associates with suicide. Epigenetics 2014, 9:1061-1070.
29. Meltzer C.C., Price J.C., Mathis C.A., Butters M.A., Ziolko S.K., Moses-Kolko E., Mazumdar S., Mulsant B.H., Houck P.R., Lopresti B.J., Weissfeld L.A., Reynolds C.F. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 2004, 29:2258-2265.
30. Meng Q.Y., Chen X.N., Tong D.L., Zhou J.N. Stress and glucocorticoids regulated corticotropin releasing factor in rat prefrontal cortex. Mol. Cell. Endocrinol. 2011, 342:54-63.
31. Merali Z., Du L., Hrdina P., Palkovits M., Faludi G., Poulter M.O., Anisman H. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J.Neurosci. 2004, 24:1478-1485.
32. Miller J.M., Hesselgrave N., Ogden R.T., Zanderigo F., Oquendo M.A., Mann J.J., Parsey R.V. Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder. Biol. Psychiatry 2013, 74:760-767.
33. Narushima K., Kosier J.T., Robinson R.G. Areappraisal of poststroke depression, intra- and inter-hemispheric lesion location using meta-analysis. J.Neuropsychiatry Clin. Neurosci. 2003, 15:422-430.
34. Palego L., Marazziti D., Rossi A., Giannaccini G., Naccarato A.G., Lucacchini A., Cassano G.B. Apparent absence of aging and gender effects on serotonin 1A receptors in human neocortex and hippocampus. Brain Res. 1997, 758:26-32.
35. Pandey G.N. Biological basis of suicide and suicidal behavior. Bipolar Disord. 2013, 15:524-541.
36. Pandey G.N., Ren X., Rizavi H.S., Conley R.R., Roberts R.C., Dwivedi Y. Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims. Int. J. Neuropsychopharmacol. 2008, 11:1047-1061.
37. Poulter M.O., Du L., Weaver I.C., Palkovits M., Faludi G., Merali Z., Szyf M., Anisman H. GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol. Psychiatry 2008, 64:645-652.
38. Qi X.R., Kamphuis W., Wang S., Wang Q., Lucassen P.J., Zhou J.N., Swaab D.F. Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients. Psychoneuroendocrinology 2013, 38:863-870.
39. Qi X.R., Zhao J., Liu J., Fang H., Swaab D.F., Zhou J.N Abnormal retinoid and TrkB signaling in the prefrontal cortex in mood disorders. Cereb. Cortex 2015, 25(1):75-83.
40. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., Overholser J.C., Roth B.L., Stockmeier C.A. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 1999, 45:1085-1098.
41. Richardson-Jones J.W., Craige C.P., Guiard B.P., Stephen A., Metzger K.L., Kung H.F., Gardier A.M., Dranovsky A., David D.J., Beck S.G., Hen R., Leonardo E.D. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 2010, 65:40-52.
42. Roth T.L., Lubin F.D., Funk A.J., Sweatt J.D. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol. Psychiatry 2009, 65:760-769.
43. Saitoh F., Tian Q.B., Okano A., Sakagami H., Kondo H., Suzuki T. NIDD, a novel DHHC-containing protein, targets neuronal nitric-oxide synthase (nNOS) to the synaptic membrane through a PDZ-dependent interaction and regulates nNOS activity. J.Biol. Chem. 2004, 279:29461-29468.
44. Shelton R.C., Sanders-Bush E., Manier D.H., Lewis D.A. Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience 2009, 158:1406-1415.
45. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983, 36:165-186.
46. Tauscher J., Verhoeff N.P., Christensen B.K., Hussey D., Meyer J.H., Kecojevic A., Javanmard M., Kasper S., Kapur S. Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET. Neuropsychopharmacology 2001, 24:522-530.
47. Thalmeier A., Dickmann M., Giegling I., Schneider B., Hartmann Annette M., Maurer K., Schnabel A., Kauert G., Moller H.J., Rujescu D. Gene expression profiling of post-mortem orbitofrontal cortex in violent suicide victims. Int. J. Neuropsychopharmacol. 2008, 11:217-228.
48. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The stanley foundation brain collection and neuropathology consortium. Schizophr. Res. 2000, 44:151-155.
49. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. RESEARCH0034.
50. Wang S.S., Kamphuis W., Huitinga I., Zhou J.N., Swaab D.F. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol. Psychiatry 2008, 13:786-799. 741.
51. Xing G., Chavko M., Zhang L.X., Yang S., Post R.M. Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression. Schizophr. Res. 2002, 58:21-30.
52. Yates M., Ferrier I.N. 5-HT1A receptors in major depression. J.Psychopharmacol. 1990, 4:69-74.
53. Zhao J., Bao A.M., Qi X.R., Kamphuis W., Luchetti S., Lou J.S., Swaab D.F. Gene expression of GABA and glutamate pathway markers in the prefrontal cortex of non-suicidal elderly depressed patients. J.Affect Disord. 2012, 138:494-502.